DECISION: Cirrhosis - Overview of existing therapies, drugs & research needs, Pierre-Emmanuel Rautou

<p>https://decision-for-liver.eu/ The objective of the DECISION project is to enhance the understanding of the pathophysiology of decompensation of cirrhosis leading to acute-on-chronic liver failure (ACLF) or death. This consortium will take advantage of already existing large and clinically well-characterized cohorts to ultimately develop prognostic and response tests and combinatorial therapies tailored to the needs of individual patients to decrease the risk of short-term death. In this video, the project&#39;s scientific coordinator, Prof. Pierre-Emmanuel Rautou, explains the complications that can occur in cirrhosis patients and how the DECISION project aims to better stratify patients that come to the clinic with acute #decompensation (of #cirrhosis). The goal is to personalise the treatment of individual patients based on tests that can predict the expected #treatment outcome. The video is a recording of the 1st presentation given at an online patient event that was jointly organised by ELPA (https://elpa.eu/) and EF CLIF (https://efclif.com/) and took place on 9th June 2021. This project has received funding from the European Union&rsquo;s Horizon 2020 research and innovation programme under grant agreement No 847949. This video reflects only the presenter&#39;s view and the European Commission is not responsible for any use that may be made of the information it contains. Production: Beatrice Credi (ELPA) and Dr. Nina Donner (concentris) Subtitles: Nicolas Lupke https://concentris.de &copy; 2021 DECISION Related video about the MICROB-PREDICT project: https://youtu.be/bVjoI1wDUCw Related video about the A-TANGO project: https://youtu.be/5aVZe_CJpps</p>